Literature DB >> 26414284

Diagnosis and Treatment of Left-Sided Prosthetic Paravalvular Regurgitation.

Konstantinos Lampropoulos1, Constantina Aggeli, Aikaterini Megalou, John Barbetseas, Werner Budts.   

Abstract

Paravalvular leak (PVL) is a complication related to the surgical implantation of left-sided prosthetic valves. The prevalence of paravalvular regurgitation ranges between 5 and 20%. Left-sided prosthetic paravalvular regurgitation presents with a wide constellation of signs and symptoms ranging from asymptomatic murmur to heart failure, hemolysis and cardiac cachexia. Echocardiography plays a key role in imaging the PVL and can help in guiding the closure procedure with both transesophageal and intracardiac probes. Transcatheter closure of paravalvular regurgitations is an appealing prospect.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26414284     DOI: 10.1159/000439247

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  3 in total

Review 1.  A comprehensive review of the diagnosis and management of mitral paravalvular leakage.

Authors:  Mustafa Ozan Gürsoy; Ahmet Güner; Macit Kalçık; Emrah Bayam; Mehmet Özkan
Journal:  Anatol J Cardiol       Date:  2020-12       Impact factor: 1.596

Review 2.  Mitral Paravalvular Leak: Clinical Implications, Diagnosis and Management.

Authors:  Ignacio Cruz-Gonzalez; Pablo Antunez-Muiños; Sergio Lopez-Tejero; Pedro L Sanchez
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

3.  Retrospective analysis of single-center early and midterm results of transapical catheter-based mitral paravalvular leak closure with a purpose-specific device.

Authors:  Aleksejus Zorinas; Vilius Janušauskas; Giedrius Davidavičius; Rokas Šimakauskas; Lina Puodžiukaitė; Diana Zakarkaitė; Valdas Bilkis; Rasa Joana Čypienė; Robertas Stasys Samalavičius; Eustaquio M Onorato; Audrius Aidietis; Kęstutis Ručinskas
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-06-19       Impact factor: 1.426

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.